This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Yeaman, M. R. Articles by Brass, E. P. Search for Related Content PubMed PubMed Citation Articles by Yeaman, M. R. Articles by Brass, E. P.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, December 2002, p. 3883-3891, Vol. 46, No. 12
0066-4804/02/$04.00+0     DOI: 10.1128/AAC.46.12.3883-3891.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.

Synthetic Peptides That Exert Antimicrobial Activities in Whole Blood and Blood-Derived Matrices

Department of Medicine, Division of Infectious Diseases,¹ Center for Clinical Pharmacology, Harbor-UCLA Medical Center,⁴ Research and Education Institute at Harbor-UCLA, Torrance, California 90502,² Department of Medicine, UCLA School of Medicine, Los Angeles, California 90025³

Received 18 April 2002/ Returned for modification 18 June 2002/ Accepted 12 September 2002

Peptides that exert antimicrobial activity in artificial media may lack activity within blood or other complex biological matrices. To facilitate the evaluation of antimicrobial peptides for possible therapeutic utility, an ex vivo assay was developed to assess the extent and durability of peptide antimicrobial activities in complex fluid biomatrices of whole blood, plasma, and serum compared with those in conventional media. Novel antimicrobial peptides (RP-1 and RP-11) were designed based in part on platelet microbicidal proteins. RP-1, RP-11, or gentamicin was introduced into biomatrices either coincident with, or 2 h prior to, inoculation with an Escherichia coli target organism. Antimicrobial activities of peptides were assessed by quantitative culture 2 h after bacterial inoculation and compared to those of peptide-free and gentamicin controls. In whole blood and homologous plasma or serum, introduction of RP-1 or RP-11 coincident with E. coli was associated with a significant reduction in CFU per milliliter versus the respective peptide-free controls. Moreover, substantial antimicrobial activity remained when RP-1 or RP-11 was placed into whole blood or plasma 2 h prior to E. coli inoculation. These results suggest that the peptides were not rapidly inactivated within these biomatrices. Peptide antimicrobial activities were negatively affected by preincubation in serum or in heat-inactivated serum, compared with those of the respective controls. Peptides RP-1 and RP-11 were consistently effective at lower concentrations in biomatrices than in artificial media, indicating favorable antimicrobial interactions with components of blood or blood fractions. Collectively, these findings support the concept that synthetic peptides can be designed to exert potent antimicrobial activities in relevant and complex biological matrices.

This article has been cited by other articles:

• Gank, K. D., Yeaman, M. R., Kojima, S., Yount, N. Y., Park, H., Edwards, J. E. Jr., Filler, S. G., Fu, Y. (2008). SSD1 Is Integral to Host Defense Peptide Resistance in Candida albicans. Eukaryot Cell 7: 1318-1327 [Abstract] [Full Text]  
• Mangoni, M. L., Maisetta, G., Di Luca, M., Gaddi, L. M. H., Esin, S., Florio, W., Brancatisano, F. L., Barra, D., Campa, M., Batoni, G. (2008). Comparative Analysis of the Bactericidal Activities of Amphibian Peptide Analogues against Multidrug-Resistant Nosocomial Bacterial Strains. Antimicrob. Agents Chemother. 52: 85-91 [Abstract] [Full Text]  
• Jones, T., Yeaman, M. R., Sakoulas, G., Yang, S.-J., Proctor, R. A., Sahl, H.-G., Schrenzel, J., Xiong, Y. Q., Bayer, A. S. (2008). Failures in Clinical Treatment of Staphylococcus aureus Infection with Daptomycin Are Associated with Alterations in Surface Charge, Membrane Phospholipid Asymmetry, and Drug Binding. Antimicrob. Agents Chemother. 52: 269-278 [Abstract] [Full Text]  
• Mukhopadhyay, K., Whitmire, W., Xiong, Y. Q., Molden, J., Jones, T., Peschel, A., Staubitz, P., Adler-Moore, J., McNamara, P. J., Proctor, R. A., Yeaman, M. R., Bayer, A. S. (2007). In vitro susceptibility of Staphylococcus aureus to thrombin-induced platelet microbicidal protein-1 (tPMP-1) is influenced by cell membrane phospholipid composition and asymmetry. Microbiology 153: 1187-1197 [Abstract] [Full Text]  
• Xiong, Y. Q., Bayer, A. S., Elazegui, L., Yeaman, M. R. (2006). A Synthetic Congener Modeled on a Microbicidal Domain of Thrombin- Induced Platelet Microbicidal Protein 1 Recapitulates Staphylocidal Mechanisms of the Native Molecule. Antimicrob. Agents Chemother. 50: 3786-3792 [Abstract] [Full Text]  
• Nusslein, K., Arnt, L., Rennie, J., Owens, C., Tew, G. N. (2006). Broad-spectrum antibacterial activity by a novel abiogenic peptide mimic. Microbiology 152: 1913-1918 [Abstract] [Full Text]  
• Yount, N. Y., Gank, K. D., Xiong, Y. Q., Bayer, A. S., Pender, T., Welch, W. H., Yeaman, M. R. (2004). Platelet Microbicidal Protein 1: Structural Themes of a Multifunctional Antimicrobial Peptide. Antimicrob. Agents Chemother. 48: 4395-4404 [Abstract] [Full Text]  
• Yeaman, M. R., Cheng, D., Desai, B., Kupferwasser, L. I., Xiong, Y.-Q., Gank, K. D., Edwards, J. E. Jr., Bayer, A. S. (2004). Susceptibility to Thrombin-Induced Platelet Microbicidal Protein Is Associated with Increased Fluconazole Efficacy against Experimental Endocarditis Due to Candida albicans. Antimicrob. Agents Chemother. 48: 3051-3056 [Abstract] [Full Text]  
• Wei, G.-X., Bobek, L. A. (2004). In vitro synergic antifungal effect of MUC7 12-mer with histatin-5 12-mer or miconazole. J Antimicrob Chemother 53: 750-758 [Abstract] [Full Text]  
• Yeaman, M. R., Yount, N. Y. (2003). Mechanisms of Antimicrobial Peptide Action and Resistance. Pharmacol. Rev. 55: 27-55 [Abstract] [Full Text]